Search
DE EN
more info

Contact:
Phone:+49 0761 1514 440 Fax:+49 0761 1514 460 Email: info[at]falkfoundation.org

Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 2/2025

Edition 1/2025

Edition 4/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Liver and Bile

Cardiac involvement in Wilson’s disease: A retrospective cohort study

Eur J Gastroenterol Hepatol. 2022;34(11):1147–50

Wang C, Gao H, Sun J, Wang L, Li W, Zu X, Cheng P, Wei S, Zhao P

Liver and Bile

Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials

Eur J Gastroenterol Hepatol. 2023;35(1):80–8

Xu T, Liu W, Huang R

Liver and Bile

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis

J Hepatol. 2022;77(5):1349–58

John BV, Ferreira RD, Doshi A, Kaplan DE, Taddei TH, Spector SA, Paulus E, Deng Y, Bastaich D, Dahman B

Liver and Bile

Plasma ammonia levels predict hospitalization with liver-related complications and mortality in clinically stable outpatients with cirrhosis

J Hepatol. 2022;77(6):1554–63

Tranah TH, Ballester MP, Carbonell-Asins JA, Ampuero J, Alexandrino G, Caracostea A, Sánchez-Torrijos Y, Thomsen KL, Kerbert AJC, Capilla-Lozano M, Romero-Gómez M, Escudero-García D, Montoliu C, Jalan R, Shawcross DL

Liver and Bile

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

J Hepatol. 2022;77(4):1014–25

Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, Rodrigues SG, Bhardwaj A, Azam Z, Hayes PC, Jindal A, Abid S, Alvarado E, Bosch J; Carvedilol-IPD-MA-group and Baveno Cooperation: an EASL Consortium

Liver and Bile

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study

Hepatology. 2022;76(4):1000–12

D’Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Gaillard VE, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, Galle PR, Bettinger D, Bengsch B, Vogel A, Balcar L, Scheiner B, Lee PC, Huang YH, Amara S, Muzaffar M, Naqash AR, Cammarota A, Personeni N, Pressiani T, Sharma R, Pinter M, Cortellini A, Kudo M, Rimassa L, Pinato DJ

Liver and Bile

Global burden of primary liver cancer in 2020 and predictions to 2040

J Hepatol. 2022;77(6):1598–606

Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I

Liver and Bile

Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis

Hepatology. 2022;76(4):1069–78

Cullaro G, Hsu CY, Lai JC

Liver and Bile

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease

Hepatology. 2022;76(6):1563–75

Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, Simbrunner B, Bauer DJM, Eigenbauer E, Strassl R, Breuer M, Kimberger O, Laxar D, Lampichler K, Halilbasic E, Stättermayer AF, Ba-Ssalamah A, Mandorfer M, Scheiner B, Reiberger T, Trauner M